This December, the NIH’s National Center for Advancing Translational Sciences (NCATS), the ITM’s parent organization, celebrates five years of translational science innovation. From pre-clinical innovation to patient engagement, NCATS has …
ITM Investigator Jonas de Souza, MD, MBA, discusses the future of immunotherapy in head and neck cancer on OncLive. Read more about de Souza’s ITM-funded cancer research here. Source: OncLive
Sam Volchenboum, MD, PhD, ITM Associate Director and Director of ITM partner the Center for Research Informatics (CRI), recently published a letter on “contagious risk” in the Journal of the …
Former ITM co-director Lainie Ross, MD, PhD, recently published Defining Death: The Case for Choice. The book tackles the many definitions of death, along with all the ethics, consequences, and choices …
All of us at the ITM wish you a happy and healthy holiday season! With this year of great growth and success behind us, we look forward to many more good …
WTTW featured ITM investigator Diane Lauderdale, PhD, in a discussion about a recent Centers for Disease Control and Prevention and National Center for Health Statistics report stating that the average U.S. life …